back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,000
+277,778 vol $0.18 each |
3,902,778 | |
| Filed 2024-04-19 14:58 Tx date 2024-04-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
53 - Grant of warrants
|
+138,889 vol |
138,889 | |
| Filed 2024-04-19 14:56 Tx date 2023-02-01 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: NKO Consulting Corp. (Indirect Ownership)
|
Warrants
55 - Expiration of warrants
|
-1,000,000 vol |
0 | |
| Filed 2024-03-02 19:11 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-02 19:10 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Tsergas, Perry
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-02 09:11 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-02 09:10 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-02 09:06 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2024-03-02 09:05 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Heimpel Butts, Jodi Lynn
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-01 14:53 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+750,000 vol |
750,000 | |
| Filed 2024-03-01 14:50 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-01 14:49 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-01 14:48 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-01 14:44 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-01 14:44 Tx date 2022-06-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-01 14:04 Tx date 2024-02-27 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2024-03-01 13:30 Tx date 2021-06-18 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-02-08 11:31 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,500,000 | ||
| Filed 2021-12-31 12:05 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-31 12:55 Tx date 2023-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+250,000 vol $0.05 each |
350,000 | |
| Filed 2023-05-31 12:54 Tx date 2023-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,000
+100,000 vol $0.10 each |
100,000 | |
| Filed 2023-05-31 12:53 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-31 12:52 Tx date 2023-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-250,000 vol $0.05 each |
0 | |
| Filed 2023-05-31 12:51 Tx date 2023-05-29 |
$MDMA
Pharmala Biotech Holdings Inc. |
Slassi, Abdelmalik
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,000
-100,000 vol $0.10 each |
250,000 | |
| Filed 2023-05-23 12:48 Tx date 2023-05-19 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-118,918.40
-272,000 vol $0.4372 each |
500 | |
| Filed 2023-05-23 12:42 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-375,000 vol |
1,125,000 | |
| Filed 2023-05-23 12:41 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,750
+375,000 vol $0.05 each |
375,000 | |
| Filed 2023-03-28 00:31 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$17,500
+350,000 vol $0.05 each |
||
| Filed 2023-03-28 00:29 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-350,000 vol |
||
| Filed 2023-05-19 19:04 Tx date 2023-05-17 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,410
-33,500 vol $0.46 each |
247,500 | |
| Filed 2023-05-19 19:03 Tx date 2023-05-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-32,200
-70,000 vol $0.46 each |
281,000 | |
| Filed 2023-05-10 15:19 Tx date 2023-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$5,000
+100,000 vol $0.05 each |
100,000 | |
| Filed 2023-05-10 15:18 Tx date 2021-06-18 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-10 15:18 Tx date 2023-05-08 |
$MDMA
Pharmala Biotech Holdings Inc. |
de Wit, Harriet
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
50,000 | |
| Filed 2023-05-04 17:54 Tx date 2023-05-02 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-56,250
-125,000 vol $0.45 each |
351,000 | |
| Filed 2023-05-04 17:53 Tx date 2023-05-02 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-66,250
-125,000 vol $0.53 each |
476,000 | |
| Filed 2023-05-04 17:52 Tx date 2023-05-02 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,750
+375,000 vol $0.05 each |
601,000 | |
| Filed 2023-05-04 17:51 Tx date 2023-05-02 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-375,000 vol |
775,000 | |
| Filed 2023-03-28 21:26 Tx date 2023-03-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,500
+100,000 vol $0.185 each |
250,000 | |
| Filed 2023-03-28 00:32 Tx date 2023-03-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-28,140
-100,500 vol $0.28 each |
226,000 | |
| Filed 2023-03-28 00:32 Tx date 2023-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,050
-23,500 vol $0.30 each |
326,500 | |
| Filed 2023-03-28 00:31 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$17,500
+350,000 vol $0.05 each |
350,000 | |
| Filed 2023-03-28 00:30 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-28 00:29 Tx date 2023-03-16 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-350,000 vol |
1,150,000 | |
| Filed 2023-02-23 19:54 Tx date 2023-02-23 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,000
+50,000 vol $0.08 each |
150,000 | |
| Filed 2022-07-25 16:35 Tx date 2022-07-13 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+300,000 vol $0.10 each |
300,000 | |
| Filed 2022-07-25 16:33 Tx date 2022-06-24 |
$MDMA
Pharmala Biotech Holdings Inc. |
Roy, Kevin Joseph Sylvio
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-01 17:14 Tx date 2022-01-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,000
+100,000 vol $0.06 each |
100,000 | |
| Filed 2022-01-31 17:24 Tx date 2022-01-28 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$360.00
+6,000 vol $0.06 each |
6,000 | |
| Filed 2022-01-31 17:20 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Macdonald, Fraser
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-31 13:41 Tx date 2021-03-22 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-11 16:01 Tx date 2022-01-05 |
$MDMA
Pharmala Biotech Holdings Inc. |
Morris, Shane H.D.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
1,500,000 | |
| Filed 2022-01-11 15:55 Tx date 2022-01-05 |
$MDMA
Pharmala Biotech Holdings Inc. |
Kadysh, Nicholas
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,500,000 vol |
2,500,000 |